Table 2.

Frequencies of AAD incidence in episodes of antibiotics use with and without probiotic supplementation

	Value	No probiotics		Probiotics
		No AAD	AAD	No AAD	AAD
Between groups
Episodes	N (%)	53 (64%)	30 (36%)	67 (80%)	17 (20%)a
Within groups	N	53	30	67	17
Type of antibiotic used
amoxicillin/clavulanic acid	N (%)	27 (51%)	17 (57%)	30 (45%)	9 (53%)
ciprofloxacin	N (%)	26 (49%)	13 (43%)	37 (55%)	8 (47%)
Indication antibiotic prescription
urinary tract infection	N (%)	31 (58%)	14 (47%)	45 (67%)	9 (53%)
respiratory tract infection	N (%)	13 (25%)	11 (37%)	19 (28%)	8 (47%)
other	N (%)	9 (17%)	5 (17%)	3 (4%)	0 (0%)

^aSignificant difference in AAD occurrence between no probiotics and probiotics group, p = 0,022, Chi-square